Iluvien 0.19 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQWF5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,427
Award facts
- Contract value 100% obligated
- $13,427.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,427.34 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ILUVIEN 0.19 MG implants. The award, issued on December 9, 2025, with an ultimate completion date of December 31, 2025, carries no set-aside designation, indicating the contractor won through open competition. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for Department of Defense medical facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial performance capability across the federal pharmaceutical supply chain, with its parent IDC under PPV-G GEN V featuring a $499.999 billion ceiling value and extending through December 31, 2036. The contractor's product portfolio encompasses a broad range of pharmaceuticals and medical consumables, including specialty products such as ILUVIEN implants used in ophthalmologic applications. No subcontractors were identified for this delivery order, and the company's consistent track record of fulfilling diverse pharmaceutical requirements positions it as a critical supplier supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQWF5?
SPE2DR26FQWF5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FQWF5 worth?
The government has obligated $13,427 on SPE2DR26FQWF5.
Is contract SPE2DR26FQWF5 an order under another contract?
Yes. SPE2DR26FQWF5 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWF5 competed?
The extent of competition for SPE2DR26FQWF5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award